BACKGROUND: Recent interest has focused on a unique subgroup of overweight and obese individuals who have normal metabolic features despite increased adiposity. Normal-weight individuals with adverse metabolic status have also been described. However, it remains unclear whether metabolic phenotype modifies the morbidity and mortality associated with higher body mass index (BMI). PURPOSE: To determine the effect of metabolic status on all-cause mortality and cardiovascular events in normal-weight, overweight, and obese persons. DATA SOURCES: Studies were identified from electronic databases. STUDY SELECTION: Included studies evaluated all-cause mortality or cardiovascular events (or both) and clinical characteristics of 6 patient groups defined by BMI category (normal weight/overweight/obesity) and metabolic status (healthy/unhealthy), as defined by the presence or absence of components of the metabolic syndrome by Adult Treatment Panel III or International Diabetes Federation criteria. DATA EXTRACTION: Two independent reviewers extracted the data. Metabolically healthy people of normal weight made up the reference group. DATA SYNTHESIS: Eight studies (n = 61 386; 3988 events) evaluated participants for all-cause mortality and/or cardiovascular events. Metabolically healthy obese individuals (relative risk [RR], 1.24; 95% CI, 1.02 to 1.55) had increased risk for events compared with metabolically healthy normal-weight individuals when only studies with 10 or more years of follow-up were considered. All metabolically unhealthy groups had a similarly elevated risk: normal weight (RR, 3.14; CI, 2.36 to 3.93), overweight (RR, 2.70; CI, 2.08 to 3.30), and obese (RR, 2.65; CI, 2.18 to 3.12). LIMITATION: Duration of exposure to the metabolic-BMI phenotypes was not described in the studies and could partially affect the estimates. CONCLUSION: Compared with metabolically healthy normal-weight individuals, obese persons are at increased risk for adverse long-term outcomes even in the absence of metabolic abnormalities, suggesting that there is no healthy pattern of increased weight. PRIMARY FUNDING SOURCE: Intramural funds from the Leadership Sinai Centre for Diabetes.
BACKGROUND: Recent interest has focused on a unique subgroup of overweight and obese individuals who have normal metabolic features despite increased adiposity. Normal-weight individuals with adverse metabolic status have also been described. However, it remains unclear whether metabolic phenotype modifies the morbidity and mortality associated with higher body mass index (BMI). PURPOSE: To determine the effect of metabolic status on all-cause mortality and cardiovascular events in normal-weight, overweight, and obesepersons. DATA SOURCES: Studies were identified from electronic databases. STUDY SELECTION: Included studies evaluated all-cause mortality or cardiovascular events (or both) and clinical characteristics of 6 patient groups defined by BMI category (normal weight/overweight/obesity) and metabolic status (healthy/unhealthy), as defined by the presence or absence of components of the metabolic syndrome by Adult Treatment Panel III or International Diabetes Federation criteria. DATA EXTRACTION: Two independent reviewers extracted the data. Metabolically healthy people of normal weight made up the reference group. DATA SYNTHESIS: Eight studies (n = 61 386; 3988 events) evaluated participants for all-cause mortality and/or cardiovascular events. Metabolically healthy obese individuals (relative risk [RR], 1.24; 95% CI, 1.02 to 1.55) had increased risk for events compared with metabolically healthy normal-weight individuals when only studies with 10 or more years of follow-up were considered. All metabolically unhealthy groups had a similarly elevated risk: normal weight (RR, 3.14; CI, 2.36 to 3.93), overweight (RR, 2.70; CI, 2.08 to 3.30), and obese (RR, 2.65; CI, 2.18 to 3.12). LIMITATION: Duration of exposure to the metabolic-BMI phenotypes was not described in the studies and could partially affect the estimates. CONCLUSION: Compared with metabolically healthy normal-weight individuals, obesepersons are at increased risk for adverse long-term outcomes even in the absence of metabolic abnormalities, suggesting that there is no healthy pattern of increased weight. PRIMARY FUNDING SOURCE: Intramural funds from the Leadership Sinai Centre for Diabetes.
Authors: Yong-Moon Mark Park; Alexandra J White; Hazel B Nichols; Katie M O'Brien; Clarice R Weinberg; Dale P Sandler Journal: Int J Cancer Date: 2017-03-28 Impact factor: 7.396
Authors: Xiaoyun Liang; Karen L Margolis; Michael Hendryx; Thomas E Rohan; Erik J Groessl; Cynthia A Thomson; Candyce H Kroenke; Michael S Simon; Dorothy Lane; Marcia Stefanick; Juhua Luo Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-02 Impact factor: 4.254
Authors: Angela K Green; Paul F Jacques; Gail Rogers; Caroline S Fox; James B Meigs; Nicola M McKeown Journal: Obesity (Silver Spring) Date: 2014-03-08 Impact factor: 5.002
Authors: Gabriela Montenegro de Souza; Maria Eduarda de Albuquerque Borborema; Thays Maria Costa de Lucena; Ariane Fernandes da Silva Santos; Brenda Regina de Lima; Dinaldo Cavalcanti de Oliveira; Jaqueline de Azevêdo Silva Journal: Mol Biol Rep Date: 2020-10-29 Impact factor: 2.316